Growth Hormone Market By Indications (Growth Hormone Deficiency (GHD), Turner Syndrome, Prader-Willi Syndrome, Small for Gestational Age), Administrative Route (Subcutaneous, Intramuscular, Hospital Pharmacies, Retail Pharmacies/Drug Stores, Online pharmacies), Distribution Channel Distribution (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Online pharmacies), & Region for 2024-2031

Growth Hormone Market Valuation – 2024-2031

Advancements in drug delivery systems, create significant opportunities for industry expansion. Innovative technologies, such as wearable patches, needle-free devices, and autoinjectors, are enhancing the convenience and patient compliance of growth hormone therapies. Thus, the technology advancements surge the growth of market size surpassing USD 4.75 Billion in 2023 to reach the valuation of USD 7.66 Billion by 2031.

The development of long-acting formulations and implantable devices has revolutionized growth hormone delivery by allowing for extended-release and sustained therapy. These innovations reduce the frequency of dosing, improving patient adherence and treatment outcomes. Thus, the cutting-edge drug delivery systems enable the market to grow at a CAGR of 6.80% from 2024 to 2031.

>>> Get | Download Sample Report @- https://www.verifiedmarketresearch.com/download-sample/?rid=10968

To Get Detailed Analysis: Download Report PDF

Growth Hormone Market: Definition/ Overview

Human growth hormone (HGH), also known as somatotropin, is a vital peptide hormone responsible for stimulating growth, cell division, and regeneration, playing a key role in human development. Produced by the pituitary gland, hGH is crucial for normal growth during childhood and adolescence. A deficiency in growth hormone (GH) occurs when the pituitary gland fails to produce adequate amounts, leading to growth hormone deficiency (GHD). This condition can result from various factors, including genetic disorders like Prader-Willi syndrome, Turner syndrome, and idiopathic short stature (ISS), all of which can cause delayed puberty and shorter stature.

While hGH is used therapeutically to treat growth hormone deficiencies and certain medical conditions, it is also often misused by older adults, athletes, and bodybuilders as an anabolic agent for performance enhancement and anti-aging purposes. However, the U.S. Food and Drug Administration (USFDA) has not approved growth hormone for these uses, as it is considered a restricted substance.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=10968

How do the Rising Growth Hormone Deficiency (GHD) Cases Surge the Growth of the Growth Hormone Market?

 Increasing growth of hormonal deficiency incidences propels the growth of the Growth Hormone Market. Global GHD prevalence increased by 12% from 2020 to 2022, affecting approximately 1 in 4,000 children. The NIH reported that adult-onset GHD diagnosis rates rose by 15% between 2021-2023. European Endocrine Society documented a 25% increase in GHD screening programs across major healthcare facilities. The anti-aging segment of growth hormone therapy grew by 28% in 2022. US clinics reported a 35% increase in growth hormone prescriptions for age-related conditions from 2020-2022. Long-acting growth hormone formulations saw a 40% adoption rate increase in 2021. FDA approved 3 new growth hormone delivery devices between 2020-2023. Investment in smart injection devices for growth hormone delivery increased by 45% in 2022. Sports medicine segment utilizing growth hormone therapies expanded by 32% in 2021

 Therapeutic use exemptions for growth hormone in sports medicine increased by 20% from 2020-2022. Research funding for sports recovery applications rose by USD 250 Million globally. Pediatric growth hormone therapy prescriptions increased by 18% between 2020-2022. WHO reported a 25% improvement in early diagnosis rates of pediatric growth disorders. Healthcare spending on pediatric growth treatments rose by USD 1.8 Billion globally in 2022. Asia-Pacific region increased endocrine disorder treatment facilities by 35% in 2021. European healthcare systems allocated €2.5 billion for hormone disorder treatments in 2022. US insurance coverage for growth hormone treatments expanded by 22% from 2020-2023.

 How the High Treatment Costs Impede the Growth of Growth Hormone Market?

 The high cost of hormonal deficiency disease treatment impedes the growth of the Growth Hormone Market. Average annual growth hormone therapy costs range from $30,000 to $60,000 per patient in 2022. Insurance denials for growth hormone treatments increased by 25% in 2021-2022. R&D costs for new growth hormone formulations averaged USD 800 Million per drug development cycle

WHO reported that 65% of patients in developing countries couldn’t access treatment due to cost barriers. FDA rejection rate for growth hormone applications increased by 30% between 2020-2022. The average approval time for new growth hormone treatments extended to 3.5 years in 2022. Regulatory compliance costs increased by 40% from 2020-2023. European Medicines Agency imposed 15 new safety monitoring requirements in 2022

The side effects and safety concerns challenge the market to grow. For instance, adverse event reporting increased by 22% for growth hormone treatments in 2021. Clinical studies showed a 15% dropout rate due to side effects in 2022. Healthcare providers reported a 28% increase in patient concerns about long-term safety. Medical liability insurance for growth hormone prescribers rose by 35% in 2022-2023. WHO estimated a 45% increase in counterfeit growth hormone products from 2020-2022. Global losses due to counterfeit growth hormone products reached $2.1 billion in 2022. Regulatory authorities seized 30% more illegal growth hormone products in 2022 compared to 2020. Healthcare fraud related to growth hormone prescriptions increased by 25% in 2021

Category-Wise Acumens

How does the Increasing Awareness for Early Detection and Treatment Surge the Growth of the Growth Hormone Deficiency Segment?

 The growth hormone deficiency (GHD) segment dominates the Growth Hormone Market and is expected to maintain its leading position throughout the forecast period driven by growing awareness of the importance of early detection and treatment of GH insufficiency, as well as the introduction of innovative therapies. For instance, Ascendis Pharma A/S received an Orphan Designation from the European Commission in October 2018 for its experimental long-acting GH treatment, TransCon hGH, designed for pediatric GH deficiency.

Technological advancements in diagnostic methods have also played a crucial role in the GHD segment’s growth. More sensitive assays and advanced imaging techniques have improved the accuracy and accessibility of GHD testing, allowing for earlier and more precise detection. Early diagnosis helps ensure that treatment begins at the optimal time, improving patient outcomes and building confidence in the effectiveness of growth hormone therapies among healthcare providers and patients alike.

How the Administering Subcutaneous Injections Foster the Growth of Subcutaneous Segment?

The subcutaneous segment dominates the Growth Hormone Market, driven by the convenience and ease of administering subcutaneous injections. These injections, delivered just beneath the skin, are less painful and more user-friendly compared to intramuscular injections, making them highly appealing, particularly for patients requiring long-term treatment, such as those undergoing growth hormone therapy. The ability to administer these injections at home eliminates the need for frequent hospital visits, reducing stress for both patients and healthcare providers. This convenience enhances patient compliance and treatment adherence, which is crucial for the effectiveness of growth hormone therapy, thereby increasing the likelihood of patients choosing and maintaining these therapies.

Technological advancements in injection devices, such as pen injectors and auto-injectors, have further streamlined the process, improving patient comfort and ensuring more precise dosing. These user-friendly devices significantly reduce the anxiety associated with traditional syringe injections. Pediatric patients, who represent a large portion of the Growth Hormone Market, particularly benefit from the reduced discomfort and simplicity of administration, encouraging parents to opt for these treatments. Additionally, the development of long-acting growth hormones, which require fewer injections, enhances patient convenience.

Gain Access Growth Hormone Market Report Methodology

https://www.verifiedmarketresearch.com/select-licence/?rid=10968

Country/Region-wise Acumens

How the Strong Environmental Regulations and Plastic Bag Bans Accelerate the Growth of Growth Hormone Market in North America?

North America substantially dominates in the Growth Hormone Market owing to the stringent environmental regulations and ban on plastic bags. Eight US states implemented complete plastic bag bans between 2020-2022, leading to a 45% increase in paper bag demand. Canada’s Single-Use Plastics Prohibition Regulations in 2022 led to a 60% surge in paper bag adoption. The EPA reported that paper bag recycling rates reached 78% in North America by 2022. US retailers reported a 35% increase in paper bag purchases following local plastic bag restrictions. Growing consumer awareness and eco-friendly preferences. US consumer survey showed 68% preferred paper bags over plastic in 2022, up from 45% in 2020. North American retailers reported a 55% increase in customer requests for paper packaging from 2020-2023. Sustainable packaging initiatives by major retail chains led to a 40% growth in paper bag consumption

In addition, the expansion of e-commerce and food delivery services also contributes to the growth of the Growth Hormone Market in the region. US e-commerce packaging demand increased by 42% between 2020-2022, with paper bags accounting for 35% of packaging materials. Food delivery services reported a 50% increase in paper bag usage from 2021-2023. The restaurant industry’s paper bag consumption grew by 38% in 2022 compared to 2020. North American quick-service restaurants increased paper bag orders by 45% in 2022.

How does the Rapid Growth in Retail and E-commerce Sectors Escalate the Growth of the Growth Hormone Market in Asia Pacific?

 Asia Pacific is anticipated to witness the fastest growth in the Growth Hormone Market during the forecast period. China’s e-commerce packaging demand grew by 65% from 2020-2022, with paper bags representing 40% of packaging materials. India’s organized retail sector expanded by 42% in 2022, driving paper bag consumption up by 38%. Southeast Asian online retail platforms reported a 55% increase in paper packaging usage between 2021-2023.

Japan’s convenience store chains increased paper bag orders by 45% following plastic reduction initiatives. India’s nationwide single-use plastic ban in 2022 led to a 70% surge in paper bag demand. China’s plastic reduction policies resulted in 52% growth in paper packaging adoption across major cities in 2022. Southeast Asian countries reported a 45% increase in paper bag manufacturing capacity following stricter plastic regulations. South Korea’s paper bag consumption rose by 35% after implementing plastic reduction targets in 2021.

Asia Pacific’s middle-class population grew by 25% from 2020-2022, correlating with a 30% increase in eco-friendly packaging preferences. Consumer surveys showed that 62% of urban Asian consumers are willing to pay a premium for sustainable packaging in 2022. Japanese retailers reported a 48% increase in customer requests for paper bags over plastic alternatives. Australian consumers’ spending on eco-friendly packaging increased by 40% between 2021-2023.

 Competitive Landscape

 The Growth Hormone Market is dominated by a few major pharmaceutical companies that have established strong brands and extensive distribution networks. These companies are constantly engaged in research and development to introduce innovative products and expand their market share.

 The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Growth Hormone Market include Eli Lilly and Company, Pfizer, Inc., Merck & Co., Inc., Novo Nordisk A/S, Roche Holding AG, Genetech, Inc. (A subsidiary of Roche Holding AG), Jiangsu Hengrui Medicine Co., Ltd., Zhengzhou Beitong Pharmaceutical Co., Ltd., LG Chem, Ltd. 

Latest Developments

• In December 2021, Pfizer Inc. announced to invest around USD 68.5 Million in a new facility in North Carolina to improve gene therapy capabilities.
• In November 2021, Novo Nordisk announced that it had reached a formal deal to acquire Dicerna Pharmaceuticals.

Report Scope

Growth Hormone Market, By Category

Indications:

• Growth Hormone Deficiency (GHD)
• Turner Syndrome
• Prader-Willi Syndrome
• Small for Gestational Age

Administrative Route:

• Subcutaneous
• Intramuscular

Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies/Drug Stores
• Online pharmacies

Geography:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.